✦ LIBER ✦

617: Efficacy of conservative treatment, fludrocortisone, and domperidone for symptomatic orthostatic hypotension in Parkinson’s disease

✍ Scribed by Kerrie L. Schoffer; John D. O’Sullivan; Karen O’Maley; Robert Henderson

Book ID: 116674247
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 46 KB
Volume: 14
Category: Article
ISSN: 0967-5868
DOI: 10.1016/j.jocn.2007.02.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nonpharmacological treatment, fludrocort

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease

✍ Kerrie L. Schoffer; Robert D. Henderson; Karen O'Maley; John D. O'Sullivan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract There is limited evidence for the treatment of orthostatic hypotension in idiopathic Parkinson's disease. The objective of this study was to determine the efficacy of three treatments (nonpharmacological therapy, fludrocortisone, and domperidone). Phase I assessed the compliance, safety

The prevalence of symptomatic orthostati

The prevalence of symptomatic orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism

✍ Ainhi D. Ha; Caitlin H. Brown; Michele K. York; Joseph Jankovic 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Leads for the development of neuroprotec

Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy

✍ Johannes C Stoof; Ania Winogrodzka; Freek L van Muiswinkel; Erik Ch Wolters; Pie 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Safety and efficacy of botulinum toxin t

Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial

✍ Robert Chinnapongse; Kristen Gullo; Paul Nemeth; Yuxin Zhang; Lynn Griggs 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 854 KB

## Abstract Sialorrhea (drooling) is a common symptom of Parkinson's disease (PD) that can significantly impair a patient's health and quality of life. Fifty‐four PD subjects with troublesome sialorrhea were enrolled using a multicenter, randomized, double‐blind, sequential‐dose escalation design i

Efficacy and safety of opicapone, a new

Efficacy and safety of opicapone, a new COMT-inhibitor, for the treatment of motor fluctuations in Parkinson's Disease patients: BIPARK-II study

✍ Lees, A.; Ferreira, J.J.; Costa, R.; Rocha, J.-F.; Oliveira, C.; Lopes, N.; Nune 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

[International Review of Neurobiology] A

[International Review of Neurobiology] Adenosine Receptors in Neurology and Psychiatry Volume 119 || Mode of Action of Adenosine A2A Receptor Antagonists as Symptomatic Treatment for Parkinson's Disease

✍ Mori, Akihisa 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 499 KB

This well-established international series examines major areas of basic and clinical research within neuroscience, as well as emerging and promising subfields. This volume concentrates on adenosine receptor science, providing insights useful for actual drug discovery/development in neurology and ps